Variability in shiga toxin binding and P-K blood group expression in individual platelet donors

Variability in shiga toxin binding and P-K blood group expression in individual platelet donors

Cooling, L.L.W.; Walker, K.E.; Koener, T.A.W.

Transfusion 35(10 Suppl): 18S

1995

ISSN/ISBN: 0041-1132

(PDF emailed within 1 workday: $29.90)

Accession: 034181642

Download citation: RIS BibTeX Text

Related references

A mutant Shiga-like toxin IIe bound to its receptor Gb(3): structure of a group II Shiga-like toxin with altered binding specificity. Structure 8(3): 253-264, 2000

Shiga toxin binding correlates with P1 blood group antigen in human adult and cord erythrocytes. Glycobiology 11(10): 903, 2001

Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing shiga toxin 1 and shiga toxin 2. Journal of Infectious Diseases 201(7): 1081-1083, 2010

Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis. Journal of Bacteriology 172(2): 653-658, 1990

Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor. Journal of Clinical Microbiology 27(6): 1145-1150, 1989

Binding of [125I]Shiga-like Toxin-1 to Human Endothelial Cells: Implications for the Pathogenesis of Shiga Toxin-associated Hemolytic Uremic Syndrome. Endothelium 3(2): 159-170, 1995

Quantitation and localization of shiga toxin/shiga-like toxin-binding glycolipid receptors in human and baboon tissues. Karmali, M A, Goglio, A G International Congress Series; Recent advances in verocytotoxin producing Escherichia coli infections 189-195, 1994

Inhibition of elongation factor 1 dependent aminoacyl transfer rna binding to ribosomes by shiga like toxin i vt1 from escherichia coli o157 h7 and by shiga toxin. FEMS Microbiology Letters 44(1): 91-94, 1987

The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. Diagnostic Microbiology and Infectious Disease 59(3): 235-242, 2007

Influence of the culture parameters on growth and Shiga toxin expression of Shiga-toxin producing Escherichia coli (STEC). Zycie Weterynaryjne 82(9): 756-762, 2007

Hybridization of Escherichia coli producing Shiga-like toxin I, Shiga-like toxin II, and a variant of Shiga-like toxin II with synthetic oligonucleotide probes. Infection and Immunity 57(9): 2811-2814, 1989

Effects of fosfomycin on Shiga toxin-producing Escherichia coli: quantification of copy numbers of Shiga toxin-encoding genes and their expression levels using real-time PCR. Journal of Medical Microbiology 58(Pt 7): 971-973, 2009

Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 22(3): 749-755, 2007

Renal Shiga toxin-1 binding and receptor expression do not vary with age. Modern Pathology 16(1): 266A, 2003

Simple method for Shiga toxin 2e purification by affinity chromatography via binding to the divinyl sulfone group. Plos one 8(12): E83577, 2013

< Previous

∧ Chapter

Next >

© 2022 EurekaMag OÜ, Sakala 7-2, 10141 Tallinn, Estonia, Tel: +372 69 91692
Registry code: , Legal Entity Identifier (LEI): 984500A2C1AE68HDA873
Privacy · Disclaimer · Terms · Contact · 浙ICP备10204677号-1